InspireMD Inc. Common Stock (NSPR)
Stock · NASDAQ · Health Care
$0.46as of 10/16/2026
Price chart
NSPR Signal Track Record
How signals performed across all stocks →What NSPR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 47 | -5.9% | 23% | September 29, 2026 |
| Bollinger Band Breakdown | 31 | -2.0% | 45% | October 1, 2026 |
| Bollinger Band Breakout | 16 | -6.6% | 31% | August 10, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -5.2% | 30% | March 20, 2025 |
| Any 20-session window (baseline) | -3.5% | 35% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NSPR
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic preven…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 127
- Website
- www.inspiremd.com/en/
Fundamentals
- 1-day range
- $0.4604$0.5
- Market cap
- $33.87M
- P/E (trailing)
- —
- P/E (forward)
- -0.97
- EPS (trailing)
- $-0.65
- Dividend yield
- —
- Beta
- 0.88
- Avg. volume
- 82.9K
- Dividend pay date
- April 1, 2019
How InspireMD Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 12, 2025 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
InspireMD Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NSPRInspireMD Inc. Common Stock$0.46▼ 4.17%Market cap $33.87MP/E —$0.4604$2.54
- ARAYAccuray Incorporated Common Stock$0.16▼ 5.88%Market cap $33.63MP/E —$0.1615$1.86
- PAVMPAVmed Inc. Common Stock$2.41▼ 0.62%Market cap $35.93MP/E —$2.27$28.44
- TELATELA Bio Inc. Common Stock$0.975▼ 3.47%Market cap $38.50MP/E —$0.5011$1.56
- NEPHNephros Inc. Common Stock$3.65▲ 3.99%Market cap $38.98MP/E 21.52$2.66$6.42
- BEATHeartbeam Inc. Common Stock$0.436▲ 0.93%Market cap $28.33MP/E —$0.355$4
- CNSYCerenome Inc. Common Stock$1.7▼ 9.57%Market cap $26.57MP/E —$1.49$4.16
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NSPR InspireMD Inc. Common Stock | $33.87M | — | $0.46 | ▼ 4.17% | $0.4604$2.54 |
| ARAY Accuray Incorporated Common Stock | $33.63M | — | $0.16 | ▼ 5.88% | $0.1615$1.86 |
| PAVM PAVmed Inc. Common Stock | $35.93M | — | $2.41 | ▼ 0.62% | $2.27$28.44 |
| TELA TELA Bio Inc. Common Stock | $38.50M | — | $0.975 | ▼ 3.47% | $0.5011$1.56 |
| NEPH Nephros Inc. Common Stock | $38.98M | 21.52 | $3.65 | ▲ 3.99% | $2.66$6.42 |
| BEAT Heartbeam Inc. Common Stock | $28.33M | — | $0.436 | ▲ 0.93% | $0.355$4 |
| CNSY Cerenome Inc. Common Stock | $26.57M | — | $1.7 | ▼ 9.57% | $1.49$4.16 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Paul Stuka · September 18, 2026 · J87.5K
- Paul Stuka · September 18, 2026 · J43.8K
- Michael Berman · September 18, 2026 · J61.2K
- Michael Berman · September 18, 2026 · J30.6K
- Gary S. Roubin · September 18, 2026 · J30.6K
- Gary S. Roubin · September 18, 2026 · J15.3K
- Paul Stuka · May 27, 2026 · Buy20.0K @ $0.875
- Shane Thomas Gleason · May 19, 2026 · Sale22.8K @ $1.01
- Paul Stuka · May 14, 2026 · Buy5.0K @ $1.15
- Paul Stuka · May 13, 2026 · Buy10.0K @ $1.16
- Marvin Slosman · May 12, 2026 · Buy21.0K @ $1.2
- Paul Stuka · May 11, 2026 · Buy10.0K @ $1.19
- Paul Stuka · May 8, 2026 · Buy65.6K @ $1.16
- Paul Stuka · May 7, 2026 · Buy6.4K @ $1.15
- Scott R. Ward · May 7, 2026 · Buy73.3K @ $1.15
Institutional Ownership
March 31, 2026
- Total shares held
- 22.78M
- Total value held
- $36.51M
- Institutional holders
- 34
- Unknown3.91M
- Unknown3.38M
- Unknown3.17M
- Unknown3.13M
- Unknown2.42M
- Unknown2.10M
- Unknown1.86M
- Unknown1.05M
- Unknown450.5K
- Unknown379.3K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
InspireMD (NSPR) noted in pre‑market health‑care stock moves
NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.
InspireMD (NSPR) noted in pre‑market health‑care stock moves. NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.